// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Ischemic and Perfused Kidney Treated with Non-Cultured Adipose-Derived Regenerative Cells Increase the Immune and Regulatory Transcriptome

R. Lathan - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Kidney Transplantation from Extended-Criteria Donors: An Increased Risk of Ureteral and Urinary Complications? Study from 10279 Patients

B. Mesnard - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Kidneys from AKI Donors with Poor Long-Term Outcomes Present an Impaired Protein Expression for Cellular Stress and Repair

F. Neri - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Living Kidney Donor Assessment: Kidney Length versus Differential Function

K. J. Schumacher - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Long Term Vasculobiliary Problems Associated with Hepatic Artery Stenosis Following Liver Transplant

R. Seth - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Low Diagnostic Yield of Protocol Allograft Biopsy Performed During DGF in Deceased Donor Kidney Transplant Recipients Treated with Induction and Standard-Dose CNI-Based Maintenance

E. Favi - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Basiliximab

Mesenchymal Stromal Cell Treatment of Kidneys During Normothermic Machine Perfusion is Safe and Feasible with Effective Traceability after Transplantation

K. Rozenberg - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Modelling Patient Outcomes after Listing for Deceased Donor Kidney Transplantation in the UK: A Novel Technique

M. Ibrahim - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Diabetic nephropathy

N/A

Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients

S. J. Yusuf - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Skin carcinoma

Mycophenolate mofetil

Normothermic Machine Perfusion of Extended Criteria Donor Livers: Identification of Protein Biomarkers Predictive of Graft Viability and Post-Transplant Complications

L. L. Wallace - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcome of Induction Therapies in Low Sensitized Renal Transplant Recipients with Two HLA DR Mismatch in Tacrolimus Era

K. Soliman - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Transplant rejection

Mycophenolate mofetil

Outcome of Large Donor-Recipient Age Gap in Live-Donor Renal Transplant in Tacrolimus Era

K. Soliman - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tacrolimus

Outcomes of Early versus Late Rejection in Kidney Transplant Recipients

A. Jaffer - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes of Pregnancy in Simultaneous Pancreas and Kidney (SPK) Transplant Recipients

S. Punjala - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What Happens When You Administer Mesenchymal Stromal Cells During Normothermic Machine Perfusion of Porcine Kidneys: Possible and Helpful or Not?

K. Rozenberg - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Preformed Anti-HLA Donor-Specific Antibodies Immunological Risk Assessment: The Importance of HLA Antibody Locus-Specificity

V. Jucaud - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Basiliximab

Ready for Transplantation: Getting the Right Messages Across at the Right Time

D. Goodall - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Renal Transplantation Into Urinary Diversions and Reconstructed Bladders

J. J. Chong - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Risk Factors for BK Virus Infection after Kidney Transplantation in the Contemporary Era: A Single-Centre Observational Study

N. Phagura - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

BK virus nephropathy

N/A

Risk Stratification in Antibody Incompatible Kidney Transplantation: Can Aggressive Rejection be Avoided?

S. Punjala - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved